Medication info
Sitagliptin Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)

Sitagliptin Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pale yellow pink round film-coated tablets with both sides convex
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202100076 · Approved 2021.01.05 · Insurance code 646005620

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with diet and exercise therapy, and in patients who have not previously received diabetes medication therapy and find it difficult to control blood sugar with monotherapy, it can be given in combination with Metformin. Additionally, when adequate blood sugar control is not achieved with monotherapy of medications such as sulfonylureas, Metformin, thiazolidinediones, or insulin, this medication can be combined to control blood sugar levels. If blood sugar control remains challenging even with combination therapy, this medication may be added to assist in blood sugar management. It effectively manages blood sugar, aiding in the treatment of diabetes.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can rarely cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, it should be stopped immediately and medical attention should be sought. Acute pancreatitis, a serious inflammation of the pancreas, may occur during treatment with this medication; if symptoms such as abdominal pain, vomiting, or nausea develop, consult a physician immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should not be administered to those with a known allergy to this medication or its ingredients. Patients with reduced kidney function should have their dose adjusted, and regular kidney function tests should be performed under the supervision of a physician. During treatment, side effects such as upper respiratory tract infections, nasopharyngitis, headaches, diarrhea, nausea, etc. may occur, and hypoglycemic symptoms may also arise, thus careful blood sugar management is essential. When used in combination with other hypoglycemic agents such as insulin or sulfonylureas, the risk of hypoglycemia increases, and dosage adjustments of the other medications may be considered if necessary. If severe joint pain or skin blisters occur, consult a physician immediately, as the medication may need to be discontinued in such cases. Pregnant or breastfeeding women should avoid using this medication, and safety in children under 18 has not been established. Elderly patients may have decreased kidney function, so regular kidney function tests are recommended during treatment, and dose adjustments may be necessary. In case of overdose, general supportive care should be provided, and blood dialysis may be used to remove some of the medication if needed. The potential for drug interactions with this medication is low, but it is important to consult a physician when taking other medications.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 30 more
  • nausea
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • severe and disabling arthralgia
  • blistering pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container that is well-sealed, and it is recommended to keep it at room temperature between 1°C and 30°C. This helps to maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Pale yellow pink round film-coated tablets with both sides convex

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.